47 results about "Particulate system" patented technology

Arrays of microparticle populations, each population labeled with a single fluorescent dye, are provided for use in multiplex assays. The populations form a virtual multidimensional array wherein each microparticle is identified by fluorescence intensity in two different fluorescence detection channels. The arrays are useful in a variety of assays, including multiplex, multi-analyte assays for the simultaneous detection of two or more analytes by, for example, flow cytometry, and a labeling reagents in, for example, microscopy. The use of singly-dyed microparticles to form multidimensional arrays greatly simplifies the creation of multiplex assays.

Provided is a production method for the particulate water-absorbing agent, which can contribute to property enhancement, and further improvement of productivity or the like, as well. One example of the production method for the particulate water-absorbing agent relevant to the present invention includes the polymerization step for obtaining a polymer gel; the drying step for drying the polymer gel to obtain a dried substance; the pulverization step for pulverizing the dried substance or the polymer gel to obtain the particulate water-absorbing resin; the classification step for sieving the particulate water-absorbing resin; the granule sizing step for granule sizing the particulate water-absorbing agent obtained from the particulate water-absorbing resin; and the transporting step for transporting the products produced in each of the steps to other steps. Preferably, one or more steps selected from the pulverization step, the classification step, the granule sizing step and the transporting step after the pulverization step are set under reduced pressure state.

In accordance with the present invention, there are provided compositions and methods useful for the in vivo delivery of substantially water insoluble pharmacologically active agents (such as the anticancer drug paclitaxel) in which the pharmacologically active agent is delivered in the form of suspended particles coated with protein (which acts as a stabilizing agent). In particular, protein and pharmacologically active agent in a biocompatible dispersing medium are subjected to high shear, in the absence of any conventional surfactants, and also in the absence of any polymeric core material for the particles. The procedure yields particles with a diameter of less than about 1 micron. The use of specific composition and preparation conditions (e.g., addition of a polar solvent to the organic phase), and careful selection of the proper organic phase and phase fraction, enables the reproducible production of unusually small nanoparticles of less than 200 nm diameter, which can be sterile-filtered. The particulate system produced according to the invention can be converted into a redispersible dry powder comprising nanoparticles of water-insoluble drug coated with a protein, and free protein to which molecules of the pharmacological agent are bound. This results in a unique delivery system, in which part of the pharmacologically active agent is readily bioavailable (in the form of molecules bound to the protein), and part of the agent is present within particles without any polymeric matrix therein.